Publication scientifique

Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease (Sanami et al., 2025)

Citation : Sanami, S., Intzandt, B., Huck, J., Villeneuve, S., Iturria-Medina, Y., Gauthier, C. J., & PREVENT-AD Research Group (2025). Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease. Neurobiology of aging, 152, 43–53. https://doi.org/10.1016/j.neurobiolaging.2025.04.011 Full text : Here Longitudinal Relationships Among Cerebrospinal Fluid […]

Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease (Sanami et al., 2025) Read More »

Differential effects of aging, Alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults (Fischer et al., 2025)

Citation : Fischer, L., Adams, J. N., Molloy, E. N., Vockert, N., Tremblay-Mercier, J., Remz, J., Pichet Binette, A., Villeneuve, S., Maass, A., & PREVENT-AD Research Group. (2025). Differential effects of aging, alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01742-6 Full text :

Differential effects of aging, Alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults (Fischer et al., 2025) Read More »

Plasma p-Tau217 and Tau-PET Predict Future Cognitive Decline Among Cognitively Unimpaired Individuals: Implications for Clinical Trials (Ossenkoppele et al., 2025)

Citation : Ossenkoppele, R., Salvadó, G., Janelidze, S., Pichet Binette, A., Bali, D., Karlsson, L., Palmqvist, S., Mattsson-Carlgren, N., Stomrud, E., Therriault, J., Rahmouni, N., Rosa-Neto, P., Coomans, E. M., van de Giessen, E., van der Flier, W. M., Teunissen, C. E., Jonaitis, E. M., Johnson, S. C., Villeneuve, S., … Hansson, O. (2025). Plasma

Plasma p-Tau217 and Tau-PET Predict Future Cognitive Decline Among Cognitively Unimpaired Individuals: Implications for Clinical Trials (Ossenkoppele et al., 2025) Read More »

Tau PET Positivity in Individuals With and Without Cognitive Impairment Varies with Age, Amyloid-β Status, APOE Genotype and Sex (Ossenkoppele et al., 2025)

Citation : Ossenkoppele, R., Coomans, E. M., Apostolova, L. G., Baker, S. L., Barthel, H., Beach, T. G., Benzinger, T. L., Betthauser, T., Bischof, G. N., Bottlaender, M., Bourgeat, P., den Braber, A., Brendel, M., Brickman, A. M., Cash, D. M., Carrillo, M. C., Coath, W., Christian, B. T., Dickerson, B. C., … Hansson, O.

Tau PET Positivity in Individuals With and Without Cognitive Impairment Varies with Age, Amyloid-β Status, APOE Genotype and Sex (Ossenkoppele et al., 2025) Read More »

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease (Gonzalez-Ortiz et al., 2025)

Citation : Gonzalez-Ortiz, F., Kirsebom, B.-E., Yakoub, Y., Gundersen, J. K., Pålhaugen, L., Waterloo, K., Selnes, P., Jarholm, J. A., Gísladóttir, B., Rongve, A., Skogseth, R. E., Bråthen, G., Aarsland, D., Turton, M., Harrison, P., Zetterberg, H., Villeneuve, S., Fladby, T., & Blennow, K. (2025). Associations between changes in levels of phosphorylated tau and severity

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease (Gonzalez-Ortiz et al., 2025) Read More »

Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression (Picard et al., 2025)

Citation : Picard, C., Zetterberg, H., Blennow, K., Villeneuve, S., Poirier, J., & on behalf of the PREVENT-AD Research Group. (2025). Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression. Genes, 16(7), 818. https://doi.org/10.3390/genes16070818 Full text : Here Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression Cynthia Picard, Henrik Zetterberg,

Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression (Picard et al., 2025) Read More »

Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer’s disease. (Tremblay SA. et Al., 2025)

Citation : Tremblay, S. A., Nathan Spreng, R., Wearn, A., Alasmar, Z., Pirhadi, A., Tardif, C. L., Chakravarty, M. M., Villeneuve, S., Leppert, I. R., Carbonell, F., Medina, Y. I., Steele, C. J., Gauthier, C. J., & PREVENT-AD Research Group (2025). Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals

Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer’s disease. (Tremblay SA. et Al., 2025) Read More »

Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. (Bussy A. et al., 2025)

Citation : Bussy, A., Patel, R., Parent, O., Salaciak, A., Bedford, S. A., Farzin, S., Tullo, S., Picard, C., Villeneuve, S., Poirier, J., Breitner, J. C., Devenyi, G. A., PREVENT-AD Research Group, Tardif, C. L., & Chakravarty, M. M. (2025). Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. Neurobiology of aging,

Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. (Bussy A. et al., 2025) Read More »

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025)

Citation : Wiesman, A. I., Madge, V., Fon, E. A., Dagher, A., Collins, D. L., Baillet, S., & PREVENT-AD Research Group and Quebec Parkinson Network (2025). Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. Brain : a journal of neurology, 148(3), 875–885. https://doi.org/10.1093/brain/awae295. Full text : Here Associations between neuromelanin depletion and

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025) Read More »

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025)

Citation : Tremblay, C., Rahayel, S., Pastor-Bernier, A., St-Onge, F., Vo, A., Rheault, F., Daneault, V., Morys, F., Rajah, N., Villeneuve, S., Dagher, A., PREVENT-AD Research Group , & Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2025). Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. Brain communications, 7(2), fcaf099. https://doi.org/10.1093/braincomms/fcaf099 Full text

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025) Read More »